News
As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...
A new trial involving 17,000 people on weight loss drugs found they reduced the risk of stroke and heart disease by half.
In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...
For the last few months, not a day has gone by where tariffs haven’t been on the tip of everyone’s tongue. The economic ...
WeightWatchers filed for bankruptcy to try to reduce debt as it expands its telehealth business. In this photo illustration, ...
Recent research suggests that Ozempic and other GLP-1 receptor agonists, commonly used for weight loss, may offer unexpected ...
These GLP-1 drugs have proven effective at helping people lose weight—and are showing promise for a host of other indications ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback